# Skylake Co., Ltd. – FDA Inspection, Jul 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/skylake-co-ltd/81012668-3c94-4b9f-ad18-7765d0aa0c8d
Source feed: FDA_Inspections

> FDA inspection 1062645 of Skylake Co., Ltd., July 17, 2018. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062645
- Company Name: Skylake Co., Ltd.
- Inspection Date: 2018-07-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nancy-m-espinal/f4494790-6a37-4998-853c-f859a0eb3330)

Company: https://www.keypedia.com/companies/skylake-co-ltd/89f29b1d-49f9-4b2a-bda7-4da0cc83134d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c